Skip to content
MarketScale
Demo
‹ Back to IndustriesSciences

Defying skepticism, SpaceX launches the Falcon Heavy rocket

SpaceX hopes to launch its Falcon Heavy rocket this Tuesday, defying skeptics and correcting past failures. If successful, the Falcon Heavy would be the world’s most powerful rocket and a huge step for the company. Viewable on the SpaceX website and YouTube, the launch aims to go off at 1:30 PM Eastern, with a backup…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences ·
Share
Defying skepticism, SpaceX launches the Falcon Heavy rocket

Key takeaways

01

SpaceX hopes to launch its Falcon Heavy rocket this Tuesday, defying skeptics and correcting past failures.

02

If successful, the Falcon Heavy would be the world’s most powerful rocket and a huge step for the company.

03

Viewable on the SpaceX website and YouTube, the launch aims to go off at 1:30 PM Eastern, with a backup…

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Request an invite

SpaceX hopes to launch its Falcon Heavy rocket this Tuesday, defying skeptics and correcting past failures. If successful, the Falcon Heavy would be the world’s most powerful rocket and a huge step for the company. Viewable on the SpaceX website and YouTube, the launch aims to go off at 1:30 PM Eastern, with a backup launch on Wednesday if weather is poor.

The Falcon Heavy will be the most powerful rocket launched since Apollo’s Saturn 5 and the first without government aid. Founder Elon Musk aims to colonize Mars in the near future and Falcon Heavy is no small part of that vision. Given the opportunity, would you become a Martian?

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Lab automation ROI hinges on integration, not instrument sensitivity claims

Lab automation ROI hinges on integration, not instrument sensitivity claims

At ADLM 2026, Waters and LabCollector delivered a clear message for lab leaders: the limiting factor in automation is often integration, not hardware. Waters introduced the Xevo TQ Absolute XR IVD mass spectrometer and is positioning it at “5x greater sensitivity” versus in-class instruments, according to SelectScience, but that advantage only carries through if sample prep, calibration and QA, middleware rules, and LIMS result review can keep pace. In parallel, LabCollector announced an AI Co-Scientist feature set for natural-language search, knowledge retrieval, and AI-assisted content creation inside ELN and LIMS workflows, also reported by SelectScience, shifting attention from pipetting speed to retrieval, approval, permissions, and versioning in systems that sit on the documentation path. The Scientist’s overview of semi-automated versus fully automated approaches reinforces the point: labs can automate in modules, but they have to run automation as one system.

  • 01The bottleneck in automation is often the handoff, instrument to middleware to LIMS, so sensitivity and throughput gains depend on interfaces and downstream review as much as the instrument spec.
  • 02Waters’ “5x greater sensitivity” positioning and LabCollector’s AI Co-Scientist both point to integration work, sample prep, calibration and QA, middleware rules, and LIMS result review, as the gating factor for ROI.
  • 03As ELN/LIMS add conversational search and AI-assisted content creation, speed gains move from pipetting to retrieval, approval, permissions, and versioning inside systems that sit in regulated or audited workflows.

Sep 3, 2026

AeroVironment to co-design three autonomous helicopters for NASA's SkyFall Mars mission

AeroVironment to co-design three autonomous helicopters for NASA's SkyFall Mars mission

AeroVironment’s MacCready Works has been contracted to build three autonomous Mars helicopters for NASA's SkyFall mission. This development highlights the company's capabilities in aerospace-grade autonomy and avionics integration. The project shows a strong connection between aerospace and defense industries in terms of supply chain management.

  • 01AeroVironment is co-designing and co-manufacturing three autonomous helicopters for NASA's SkyFall Mars mission with JPL.
  • 02SkyFall will use a 'SkyFall maneuver' where three helicopters are released from a carrier spacecraft, separate, deploy, descend, and land under their own power, avoiding a dedicated lander or host rover.
  • 03AeroVironment leads rotor systems, airframes, structures, avionics integration, and payload provisions, while JPL leads the power system, electronics, algorithms, and software.

Aug 29, 2026

Telehealth "digital waiting rooms" are turning into premium pharma ad slots

Telehealth "digital waiting rooms" are turning into premium pharma ad slots

Pharmaceutical companies are increasingly using telehealth digital waiting rooms as prime advertising slots. These virtual spaces offer unique opportunities for pharma brands to engage patients before and after their virtual care visits. The trend is driven by fresh data on patient attention and strategic execution by agencies.

  • 01Pharmaceutical brands are using digital waiting rooms in telehealth platforms as premium ad slots.
  • 02New patient-attention data enhances pharma media plans for virtual care settings.
  • 03Virtual waiting rooms allow targeted patient engagement before and after healthcare consultations.

Aug 29, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For Sciences teams

See how Sciences teams use MarketScale →

Executive Thought Leadership

Explore Channels

Industry news, analysis, and expert perspectives

Professional AV›Engineering & Construction›Education Technology›Healthcare›Energy›Software & Technology›Retail›Business Services›Industrial IoT›Sports & Entertainment›Transportation›Sciences›Building Management›Food & Beverage›Architecture & Design›Hospitality›Marketing Tech›
Keep exploring

More from Sciences

Sciences hubMore expert Sciences coverage.Explore →Executive Thought LeadershipPut researchers on the record.Explore →FinThriveComplex topics, made clear.Explore →State of GEO & AI VisibilityHow B2B brands get cited by AI search.Explore →

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512